FDA To Review Piroctone Olamine For OTC Dandruff Monograph Status
This article was originally published in The Rose Sheet
Executive Summary
FDA is seeking safety and efficacy data on piroctone olamine for use as a single active ingredient in dandruff control products, the agency announced in a Federal Register 1notice Feb. 18